ASU Regents' Professor Charlie Arntzen has spent more than two decades working on ways to better deliver and produce vaccines for human consumption. Now Arntzen and his colleagues are celebrating a life saving breakthrough as the process played a role in treating a pair of Ebola virus patients.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…